The role of interleukin-6 in central nervous system demyelination

Neural Regeneration Research

Volumn 11, Issue 12, 2016, Pages 1922-1923

  Petković, Filip ^a,b   Castellano, Bernardo ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CUPRIZONE; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADENOMATOUS POLYP; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; CELL DIFFERENTIATION; DEMYELINATION; DISEASE EXACERBATION; HISTOPATHOLOGY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NOTE; PATHOGENICITY; SYMPTOMATOLOGY;

EID: 85009210576     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.195273     Document Type: Note

References (12)

1. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
2. Campbell IL, Erta M, Lim SL, Frausto R, May U, Rose-John S, Scheller J, Hidalgo J (2014) Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J Neurosci 34:2503-2513.
3. Chiang CS, Stalder A, Samimi A, Campbell IL (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci 16:212-221.
4. Erta M, Giralt M, Jiménez S, Molinero A, Comes G, Hidalgo J (2016) Astrocytic IL-6 influences the clinical symptoms of EAE in mice. Brain Sci 6:pii: E15.
5. Kipp M, Clarner T, Dang J, Copray S, Beyer C (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118:723-736.
6. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717.
7. Petković F, Campbell IL, Gonzalez B, Castellano B (2016) Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation. Glia 64:2104-2119.
8. Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161:6480-6486.
9. Schneider A, Long SA, Cerosaletti K, Ni CT, Samuels P, Kita M, Buckner JH (2013) In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling. Sci Transl Med 5:170ra15.
10. Schönrock LM, Gawlowski G, Brück W (2000) Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett 294:45-48.
11. Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M, Baumgärtner W, Stangel M (2013) Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136:147-167.
12. Streit WJ, Xue QS, Tischer J, Bechmann I (2014) Microglial pathology. Acta Neuropathol Commun 2:142.